Related Experiment Video

Updated: Aug 21, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

[Bacterial meningitis caused by Neisseria meningitidis. Prophylactic measures]

Wiesław Magdzik

    Przeglad Epidemiologiczny
    |November 4, 2004
    PubMed

    Insights

    Meningitis, a serious Neisseria meningitidis infection, has varying fatality rates. Vaccines exist for several serogroups, but research continues for a universal vaccine against all meningococcal groups.

    Area of Science:

    • * Infectious Diseases
    • * Microbiology
    • * Vaccinology

    Background:

    • * Meningitis caused by Neisseria meningitidis presents a significant public health challenge with fatality rates ranging from a few percent up to 20%.
    • * The most common causative serogroups include A, B, C, Y, and W-135.
    • * Vaccination is the primary strategy for preventing meningococcal meningitis.

    Discussion:

    • * Current vaccines include polysaccharide non-conjugated vaccines effective for specific serogroups (A, C, W-135, Y) in individuals over two years old, and a protein-conjugated vaccine for serogroup C effective from two months of age.
    • * Mass vaccination campaigns utilizing the serogroup C conjugated vaccine have been implemented, such as in Great Britain in 1998/1999.
    • * Serogroup B is a predominant cause of Neisseria meningitidis infections in Poland and other European countries.

    Key Insights:

    • * Existing vaccines target specific serogroups of Neisseria meningitidis, with varying age-appropriateness.
    • * The prevalence of serogroup B necessitates ongoing research for broader protection.
    • * Development of a universal vaccine against all serogroups remains a critical goal.

    Outlook:

    • * Continued research focuses on creating effective, safe, and affordable vaccines.
    • * Advancements in vaccinology aim to provide comprehensive protection against all major meningococcal serogroups.
    • * Future vaccines may offer broader coverage, potentially including serogroup B.

    More Related Videos

    Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells10:12

    Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells

    Published on: July 14, 2020

    Induction of Leptomeningeal Cells Modification Via Intracisternal Injection05:55

    Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

    Published on: May 7, 2020

    Related Concept Videos

    Bacterial Meningitis I: Introduction01:22

    Bacterial Meningitis I: Introduction

    Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
    Bacterial Meningitis01:24

    Bacterial Meningitis

    Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
    Bacterial Meningitis II: Pathophysiology01:26

    Bacterial Meningitis II: Pathophysiology

    Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
    Viral Meningitis01:18

    Viral Meningitis

    Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
    Cryptococcal Meningitis01:27

    Cryptococcal Meningitis

    Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
    Respiratory Syncytial Virus Disease01:29

    Respiratory Syncytial Virus Disease

    Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...